| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.05 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |